Security key
53566P109
Lineage Cell Therapeutics, Inc. - Common Stock (LCTX)
CUSIP: 53566P109
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 109,349,495
- Total 13F value
- $49,687,946
- Share change
- +2,237,919
- Put/Call ratio
- 38%
- SEC-reported price per share
- $0.45
- Number of holders
- 126
- Value change
- +$369,638
- Number of buys
- 55
- Number of sells
- 35
- Shares outstanding
- 248,782,811
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
126
Top holders
10
LCTX full security history
Ownership snapshot
Full 13F holder table
Lineage Cell Therapeutics, Inc. SEC filings
Lineage Cell Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of LCTX - Lineage Cell Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BROADWOOD CAPITAL INC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 17%
Showing 1-6 of 15 holder rows.
Quick read
BROADWOOD CAPITAL INC leads the comparable SEC ownership view at 17%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BROADWOOD CAPITAL INC's linked filing trail.
Comparable ownership
Top 5
BROADWOOD CAPITAL INC
17%
BlackRock, Inc.
4.1%
VANGUARD GROUP INC
3.5%
PERCEPTIVE ADVISORS LLC
2.9%
Defender Capital, LLC.
2.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
Company
|
17%
|
$20,937,293
41,666,255 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
4.1%
|
$5,072,576
10,094,677 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.5%
|
$4,342,363
8,632,928 shares
|
— | 31 Dec 2024 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
2.9%
|
$3,636,514
7,236,843 shares
|
— | 31 Dec 2024 |
| Defender Capital, LLC. |
13F
Company
|
2.4%
|
$2,996,582
5,963,348 shares
|
— | 31 Dec 2024 |
| RAFFLES ASSOCIATES LP |
13F
Company
|
2.2%
|
$2,759,774
5,492,088 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
126
Shares
109,349,495
Rows available
126
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
126
Q1 2025 holders
126
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|